Bausch Health settles generic dispute with Actavis
13-09-2018
Teva goes to war with Eli Lilly over migraine breakthrough
07-02-2018
Teva and Alder sign deal to overcome antibodies dispute
11-01-2018
The English High Court has refused to grant Eli Lilly an injunction which would have stopped Teva, Actavis and Mylan marketing a generic version of its drug Cialis (tadalafil).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Eli Lilly, Teva, Actavis, Mylan, English High Court, English Court of Appeal, generics, injunction, tadalafil, Cialis, supplementary protection certificate
